Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-09

Clinical Trial Update: Draw-10: A Weekly Blood Draw Study to Understand the Biological Variability of Plasma pTau-217

View source ↗

Summary

Draw-10, a weekly blood draw study investigating the biological variability of plasma pTau-217 in Alzheimer's disease, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Banner Health | Conditions: Alzheimer Disease | Status: COMPLETED